相关实验视频

Updated: May 2, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

在实验肥胖中,肝细胞独立的PAR1偏差信号控制肝脏病理

Holly Cline¹, Zimu Wei¹, Dafna J Groeneveld¹

¹Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, Michigan, USA.

Journal of thrombosis and haemostasis : JTH

|August 9, 2024

概括

在肥胖小鼠中,法定PAR1裂变,而不是在肝细胞中,驱动了与代谢功能障碍相关的脂肪性肝病 (MASLD). 药理学调节的PAR1提供了代谢的好处.

科学领域:

肝病学肝病学是一种肝病学.
代谢性疾病是一种代谢性疾病.
凝血和炎症信号发出信号.

背景情况:

蛋白酶激活受体-1 (PAR1) 将凝血与肥胖并发症联系起来,例如与代谢功能障碍相关的脂肪性肝病 (MASLD).
PAR1激活涉及不同的信号通路,由各种蛋白酶介导.
PAR1突变 (R41Q,R46Q) 可以选择性地禁用正规或非正规信号.

研究的目的:

研究PAR1信号在饮食引起的MASLD中的作用.
评估向PAR1在与肥胖相关的肝病中的治疗潜力.

主要方法:

使用 PAR1 缺乏和突变的小鼠 (R41Q,R46Q) 食高脂肪饮食 (HFD) 来诱导 MASLD.
向HFD养的肥胖小鼠注射了一种全性PAR1调节剂 (NRD-21).
评估肝硬化症,肝/体重比,血清氨酸转移酶和胰岛素抵抗.

主要成果:

被HFD养的R41Q小鼠显示肝胆固醇减少,而R46Q小鼠显示肝胆固醇增加和肝损伤.
选择性PAR1删除在肝细胞中没有影响肥胖症.
NRD-21治疗改善了肝硬化,肝酶,胰岛素抵抗和炎症标志物,同时增加了活性GLP-1.

结论:

非肝细胞法定PAR1裂变是肥胖小鼠中MASLD的一个关键驱动因素.
选择性药理学调节PAR1在实验肥胖症中提供了显著的代谢益处.

关键词:

在 PAR1 中,PAR1 是 PAR1 的第一部分.肝脏疾病肝脏疾病代谢综合征代谢综合征接收器接收器接收器接收器血栓激素血栓激素是一种

更多相关视频

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

相关概念视频

Chronic Pancreatitis II: Pathophysiology

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...